Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: Interim results of a phase I trial

[1]  P. Rampal,et al.  Hepatic intraarterial lipiodol: Technique, semiologic patterns, and value for hepatic tumors , 2005, Gastrointestinal Radiology.

[2]  A. Viel,et al.  Expression of the mdr1 gene in human colorectal carcinomas: relationship with multidrug resistance inferred from analysis of human colorectal carcinoma cell lines , 2004, Cancer Chemotherapy and Pharmacology.

[3]  S. Ishiguro,et al.  A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma , 2004, Cancer Chemotherapy and Pharmacology.

[4]  Y. Katagiri,et al.  Adriamycin-Lipiodol suspension for i. a. chemotherapy of hepatocellular carcinoma , 2004, Cancer Chemotherapy and Pharmacology.

[5]  M. Kao,et al.  The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells , 2004, Cancer Immunology, Immunotherapy.

[6]  O. Bagasra,et al.  Immune response of mice exposed to cis-diamminedichloroplatinum , 2004, Cancer Immunology, Immunotherapy.

[7]  J. Fleming,et al.  Biodistribution of lipiodol following hepatic arterial injection. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  T. Tsuruo,et al.  Establishment of multidrug resistant human colorectal carcinoma HCT-15 cell lines and their properties. , 1991, Anticancer research.

[9]  A. Johnsen,et al.  Doxorubicin in combination with verapamil in advanced colorectal cancer. A phase II trial. , 1991, Acta oncologica.

[10]  T. Konno.  Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium , 1990, Cancer.

[11]  J. K. Martin,et al.  Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. , 1990, Archives of surgery.

[12]  H. Taniguchi,et al.  Intraarterial infusion chemotherapy for metastatic liver tumors using multiple anti‐cancer agents suspended in a lipid contrast medium , 1989, Cancer.

[13]  J. Hannigan,et al.  A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Fukushima,et al.  Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma , 1989, Cancer.

[15]  E. Sigurdson,et al.  Regional hepatic arterial infusion of degradable starch microspheres increases fluorodeoxyuridine (FUdR) tumor uptake. , 1989, Surgery.

[16]  S Sawada,et al.  Transcatheter oily chemoembolization of hepatocellular carcinoma. , 1989, Radiology.

[17]  Hryniuk Wm.  The importance of dose intensity in the outcome of chemotherapy. , 1988 .

[18]  W. Hryniuk.  The importance of dose intensity in the outcome of chemotherapy. , 1988, Important advances in oncology.

[19]  A. Sodhi,et al.  Increased capacity of lymphocytes to lyse tumor cells in vitro and production of lymphotoxins after cisplatin treatment. , 1988, International journal of immunopharmacology.

[20]  P D Schneider,et al.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. , 1987, Annals of surgery.

[21]  S M Hubbard,et al.  The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture. , 1987, Cancer research.

[22]  N. Kemeny,et al.  Tumor and liver drug uptake following hepatic artery and portal vein infusion. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Lostritto,et al.  Theoretical considerations of drug release from submicron oil in water emulsions. , 1987, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[24]  N. Geller,et al.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. , 1987, Annals of internal medicine.

[25]  I. Taylor,et al.  Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model. , 1987, Gut.

[26]  W. Hryniuk,et al.  Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Makuuchi,et al.  Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. , 1987, Radiology.

[28]  J. Bading,et al.  Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein , 1987, Cancer.

[29]  G. Ratkin.  Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Priest,et al.  Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[31]  岩井 顕.  Use of oily contrast medium for selective drug targeting to tumor : enhanced therapeutic effect and X-ray image , 1986 .

[32]  J. Collins.  Pharmacologic rationale for hepatic arterial therapy. , 1986, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[33]  S. Tashiro,et al.  Selective targeting of anti‐cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium , 1984, Cancer.

[34]  W. Hryniuk,et al.  The importance of dose intensity in chemotherapy of metastatic breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  S. Tashiro,et al.  Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. , 1983, European journal of cancer & clinical oncology.

[36]  L. Zwelling,et al.  Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II). , 1980, Cancer research.

[37]  F. Schabel,et al.  cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. , 1979, Cancer treatment reports.

[38]  D. Levin,et al.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. , 1978, Cancer research.

[39]  L. M. Atkins,et al.  Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents. , 1977, Cancer treatment reports.

[40]  L. M. Atkins,et al.  Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents. , 1976, Journal of the National Cancer Institute.

[41]  G. Gale,et al.  Cyclophosphamide plus other selected antineoplastic agents. , 1976 .

[42]  H. Peterson,et al.  Experimental studies on the uptake and rentention of labelled proteins in a rat tumour. , 1973, European journal of cancer.

[43]  M. Sugiura,et al.  Hepatography for detection of small tumor masses in liver: experiences with oily contrast medium. , 1966, Surgery.